Iovance Biotherapeutics, Inc. logo

Iovance Biotherapeutics, Inc.

BrandSan Carlos, CaliforniaWebsite

Company Overview

Iovance Biotherapeutics (NASDAQ: IOVA) aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer. We are pioneering a transformational approach to cure cancer by harnessing the human immune system’s ability to recognize and destroy diverse cancer cells in each patient. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors. We are committed to continuous innovation in cell therapy, including gene-edited cell therapy, that may extend and improve life for patients with cancer.We are adding to our talented team as we execute our commercial launch, advance our research and development efforts, and build our internal manufacturing capabilities. Iovance is headquartered in the San Francisco Bay Area. Our Iovance Cell Therapy Center (iCTC), a state-of-the-art manufacturing facility, is located in Philadelphia. We also have a research site in Tampa, Florida. Any information expressed by Iovance is subject to the risk factors and information on forward-looking statements contained in its filings with the Securities and Exchange Commission and available here: https://ir.iovance.com/sec-filings
Founded
2007
Headquarters
San Carlos, California
Employees
501-1000
12% growth last 12mo
Marketing Team
15
2% of company

Marketing Team Tenure

Based on 1 marketers at Iovance Biotherapeutics, Inc.

Median Tenure
< 1
years
Leader Tenure
0
years
Tenure Distribution
1
<1 yr
0
1-3 yrs
0
3-5 yrs
0
5+ yrs

Overall Headcount Trend

Overall Headcount Trend

Company growth over the last 12 months

Salaries

Community Salary Data

Help build salary transparency at Iovance Biotherapeutics, Inc.. Share your compensation anonymously.

Contribute

Reviews

Jobs